"Prevent Breast Cancer."
Simple DNA Saliva Test To Uncover Your Inherited Risk For Breast Cancer
Breast Cancer Risk Management Sequence
What Is A Polygenic Score?
- Everyone has small genetic differences, called variants.
- These variants can affect the risk of developing certain diseases.
- A polygenic risk score (PRS) combines the effects of millions of genetic variants to estimate your disease risk.
- While each variant has a small effect, their combined impact can be significant.
Who Should Take This Test?
Female – Adult (18-75 years)
Healthy women interested in understanding their personal risk of breast cancer.
Women diagnosed with breast cancer seeking to understand the genetic factors contributing to their disease.
Women who carry a rare monogenic mutation (e.g., BRCA) associated with increased breast cancer risk.
Women with a family history of breast cancer.
How It Works - Step By Step
Developed by Avigena (USA) and Novo Genomics (Saudi Arabia), and trusted by top U.S.
institutions, this test is tailored for Middle Eastern and Arab women.
Results are ready in 4 to 8 weeks, giving you time to act early and make informed decisions.
Along with your personalized risk report, eligible patients receive a complimentary virtual
session with an Avigena genetic counselor. We’ll explain your results and help you explore
practical steps to reduce your risk.
Ask your doctor about the PRS for breast cancer—or contact us to learn more.
Your DNA can guide your prevention.